Organogenesis Inc.

AI Score

XX

Unlock

4.50
-0.17 (-3.64%)
At close: Mar 28, 2025, 3:59 PM
4.50
-0.06%
Pre-market: Mar 31, 2025, 04:02 AM EDT

Organogenesis Cash Flow Statement

Year FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15
Net Income 861K 4.95M 15.53M 94.9M 17.95M -40.45M -64.83M -2.09M -208.7K -24.26M
Depreciation & Amortization 17.03M 23.45M 18.03M 16.68M 7.47M 9.43M 6.98M 5.63M 7.32M 7.68M
Stock-Based Compensation 10.58M 9M 6.55M 3.86M 1.66M 936K 1.07M 919K 473K 459K
Other Working Capital n/a -30.08M -19.16M -3.6M -4K 1.39M -10.23M 1.51M 8.47K 3.9M
Other Non-Cash Items -3.54M 9.59M 16.85M 17.8M 5.78M 6.12M 18.25M -155.75K -303.8M 8.81M
Deferred Income Tax -10.72M 2.01M 1.98M -31.98M 112K 111K 186K n/a n/a n/a
Change in Working Capital n/a -18.07M -34.08M -39.29M -26.16M -9.67M -22.4M 1.51M -353.54K -2.89M
Operating Cash Flow 14.21M 30.92M 24.86M 61.98M 6.8M -33.53M -60.74M -586.6K -562.23K -10.19M
Capital Expenditures -10.03M -24.36M -33.9M -31.22M -21.14M -6.23M -1.86M -2.43M -1.36M -510K
Acquisitions n/a n/a n/a n/a -5.82M n/a 1K -11.79M n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a n/a n/a n/a 2.13M -250K 1K -658K -310M 121K
Investing Cash Flow -10.03M -24.36M -33.9M -31.22M -24.83M -6.23M -1.86M -14.87M -310M -389K
Debt Repayment n/a -5.17M -3.01M -2.01M -15.91M 37.23M 1.07M 100K 11.98M n/a
Common Stock Repurchased -25.48M n/a -648K -737K n/a -6.76M n/a n/a n/a n/a
Dividend Paid -1.8M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 54.91M -332K 814K 978K -6.35M -2.08M -11.43M 19.19M -5.2M 10.79M
Financial Cash Flow 27.64M -5.5M -2.2M -1.04M 42.47M 78.73M 81.64M -327.58K 311.48M 10.79M
Net Cash Flow 31.81M 1.05M -11.24M 29.72M 24.44M 38.97M 19.05M -914.18K 914.01K 204K
Free Cash Flow 4.18M 6.55M -9.04M 30.76M -14.34M -39.76M -62.6M -3.01M -1.92M -10.7M